Navigation Links
InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
Date:8/26/2013

BOSTON, Aug. 26, 2013 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, today announced it has completed the first phase of a manufacturing consolidation that the Company believes will improve its long term gross margins.

Simultaneously, the Company has signed an agreement with HealthLink Europe, a medical device support services and distribution company, to provide logistical and customer support for InspireMD's commercial operations and clinical activities.  HealthLink will provide InspireMD with customer service center capabilities for inquiries from hospitals and distributors.  HealthLink will also handle all inventory controls, warehousing, shipping, and invoicing and receivables management for customers worldwide on behalf of InspireMD.

Alan Milinazzo, President and CEO of InspireMD, commented, "We have successfully completed the first stage of our manufacturing strategy through the consolidation of our Israeli manufacturing facilities.  Over time, we believe that this will reduce our operating costs by streamlining our manufacturing operations."

"As we prepare to announce the 12-month results from the MASTER trial in October, we continue to put in place the appropriate infrastructure to be able to meet the anticipated increase in demand for our lifesaving stent technology.  The agreement with HealthLink Europe is intended to support both current commercial activities as well as ongoing clinical trials, and should provide us instant access to world-class customer logistics to support all of our customers through a single partner," concluded Mr. Milinazzo.

Rick Hughes, President of HealthLink Europe, commented "For nearly 20 years HealthLink has built an impressive track record of providing superior customer service and logistics support to the medical d
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMDs MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
2. InspireMD Reports Financial Results For Period Ended March 31, 2013
3. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
4. InspireMD Closes $25 Million Underwritten Public Offering
5. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
6. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
7. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
8. InspireMD Reports Results for Period Ended Dec. 31, 2012
9. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
10. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
11. InspireMD Reports Results For Period Ending Sept. 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... RAFAEL, Calif. , May 28, 2015   Sanovas, ... recognized as one of the Top 50 Start-Up Companies in the ... Logo - http://photos.prnewswire.com/prnh/20150528/219097LOGO ... carefully chosen panel of segment experts with direct domain experience ... on each company,s Intellectual Property, Business Model, and Team. This ...
(Date:5/28/2015)... BOULDER, Colo. , May 28, 2015  Array ... on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at ... Meeting, which will be held May 29 – June ... These three products are currently advancing in a total ... 2015 from both the NEMO (binimetinib monotherapy in NRAS ...
(Date:5/28/2015)... INDIANAPOLIS , May 28, 2015  Eli ... final results of the Phase III PROCLAIM trial ... presentation at the American Society of Clinical Oncology ... . PROCLAIM was a randomized, Phase III superiority ... lung cancer (NSCLC), which evaluated Lilly,s ALIMTA ® ...
Breaking Medicine Technology:Sanovas Awarded Global "Top-50" Start-Up Company 2Sanovas Awarded Global "Top-50" Start-Up Company 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 2PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 3PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 4PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 5PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 6PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 7PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting 8
... the United States a young competitive athlete dies suddenly every three ... of young athletes at risk for SCA can be saved if ... at-risk youths are screened by a physician. To raise awareness of ... that its educational initiative Close the Gap ...
... Inc. (NYSE: HRC ) will release its fiscal ... company will host a webcast the following morning on Thursday, ... Earnings Release:  Hill-Rom,s Fiscal 2012 First Quarter Earnings Release ... the NYSE on Wednesday, January 25, 2012.  The release will ...
Cached Medicine Technology:Boston Scientific Raises Awareness of Heart Disease at Brandon Jennings Invitational 2Boston Scientific Raises Awareness of Heart Disease at Brandon Jennings Invitational 3Hill-Rom Holdings, Inc. Hosts Fiscal 2012 First Quarter Earnings Webcast 2
(Date:5/28/2015)... Trends Investing ” was featured on NewsWatch as part of ... medium, and large businesses making an impact in their industry. ... the business review and shared with viewers how this website ... money. , The idea, “let your money work for you” ... how to succeed are two different things. So if ...
(Date:5/28/2015)... 2015 More than 300 locations of ... money to help the Muscular Dystrophy Association save and ... related life-threatening diseases that limit muscle strength and mobility ... , From June 1 to June 30, sweetFrog associates ... opportunity to help send local children affected by neuromuscular ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 According ... ( http://www.idataresearch.com ), the shoulder reconstruction device market, ... small bone & joint market in 2014. This ... arthroplasty procedures in the U.S. due to increased ... device technology resulting in greater patient outcomes. Therefore, ...
(Date:5/28/2015)... 2015 The Khanna Vision Institute announced ... application to make learning about treatment of keratoconus ... few years. This proliferation of treatment techniques has not ... of the nuances of the cutting edge technologies. Dr.Khanna, ... websites can be boring and printed material can be ...
(Date:5/28/2015)... 28, 2015 WebWatcher, the ... their partnership with BeSure Consulting to help ... The partnership will combine BeSure Consulting’s ... parental monitoring software solution. , Led by ... Consulting's passion is concentrated on teaching law ...
Breaking Medicine News(10 mins):Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 2Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 3Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:WebWatcher Partners with BeSure Consulting 2Health News:WebWatcher Partners with BeSure Consulting 3
... and television that anger causes// the cardiac arrest of ... Yale University researchers have found out that sudden strong ... in the heart to twitch. This may be especially ... although seemingly healthy people my also be affected. ...
... Surrey, UK, had developed a new// drug that will boost ... is made of a compound called CX717, and it is ... This drug had showed effectiveness in increasing memeory, alertness, increasing ... who sleep less. ,The drug was given to ...
... had successfully created a new breed of mice that can ... for themselves.//, ,The reactive oxygen of the free radicals ... to poor health and even death. The new research may ... radical theory of ageing. ,The new mice created ...
... may lead to babies born with deformed prostate glands.//, ... out that prostate deformities can happen if the pregnant ... The pills contain ostrogen like chemiclasthat are alos present ... can cause prostate cancer or bladder diseases later in ...
... study that looked into the smoking habit of 6654 people ... that giving up smoking do causes weight gain, but the ... population under study was measured for effect of giving up ... when the age group was 20 to 44yrs, and was ...
... levels of blood marker for inflammation that can //lead to ... say that it may be good for the health of ... man will have a close family, a good group of ... the workplace, or the neighbors, or a religious organization. ...
Cached Medicine News:
Qualcare™ Thumb Spica...
... QuickCast® Cast-like splints Slip on, ... and QuickCast conforms to fit. ... Reheat to adjust and reposition. ... with a temperature-sensitive polymer Straps ...
... can be difficult for persons who have ... cord injuries and for children with poor ... other motor or coordination problems. The FoamWrap ... and coordination. Soft foam-lined material provides light ...
... and the CMC joint of the thumb and has ... thumb joints. An excellent choice for active persons who ... mobility for daily activities. Ideal for persons with arthritis ... with pain due to repetitive stress. This is the ...
Medicine Products: